Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubei Huizhong Pharmaceutical is a comprehensive pharmaceutical enterprise based in China that specializes in the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and finished dosage forms. The company's product portfolio spans several critical therapeutic areas, including cardiovascular health, anti-infectives, and gastrointestinal treatments. Operating out of modern facilities in Hubei Province, the company maintains strict adherence to Good Manufacturing Practice (GMP) standards to supply both domestic and international markets. Its business model integrates chemical synthesis with advanced formulation capabilities, positioning it as a key supplier of essential medicines and chemical intermediates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hubei Huizhong Pharmaceutical.